Beam Therapeutics BEAM Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31.74M-72.2% | $114.11M+1,077% | $9.7M+14.6% | $8.47M+13.3% | $7.47M-75.2% | ||
| $104.52M+5.3% | $99.28M-9.6% | $109.77M+7.9% | $101.76M+3.0% | $98.82M-2.6% | ||
| $34.43M+6.7% | $32.28M+20.7% | $26.74M-0.4% | $26.86M-3.9% | $27.94M-2.5% | ||
| $138.95M+5.6% | $131.55M-3.6% | $136.51M+6.1% | $128.62M+1.5% | $126.76M-2.6% | ||
| -$107.22M-515% | -$17.45M+86.2% | -$126.81M-5.5% | -$120.15M-0.7% | -$119.29M-19.2% | ||
| -337.8%-323pp | -15.3%+1,292pp | -1,307.6%+112pp | -1,419.2%+178pp | -1,596.9%-1,264pp | ||
| $12.9M-95.1% | $261.74M+1,759% | $14.08M-21.1% | $17.86M+63.0% | $10.96M+13.1% | ||
| $16K— | —— | $4.94M+11.8% | $4.42M+312% | -$2.08M-90.9% | ||
| -$94.32M— | —— | -$112.73M-10.2% | -$102.29M+5.6% | -$108.33M-19.9% | ||
| -297.2%— | —— | -1,162.4%+45.9pp | -1,208.3%+242pp | -1,450.2%-1,150pp | ||
| -$0.91— | —— | -$1.10-10.0% | -$1.00+18.7% | -$1.23-12.8% | ||
| -$0.91— | —— | -$1.10-10.0% | -$1.00+18.7% | -$1.23-12.8% | ||
| 103.3M+4.4% | 98.9M-3.6% | 102.6M+0.6% | 102M+15.9% | 88M+6.9% | ||
| 103.3M+4.4% | 98.9M-3.6% | 102.6M+0.6% | 102M+15.9% | 88M+6.9% | ||
| -$514K— | —— | -$1M-3,671% | $28K+3.7% | $27K— | ||
| -$96.5M— | —— | -$111.95M-9.3% | -$102.44M+5.9% | -$108.85M-19.0% | ||
| $2.5M+4,900% | $50K+102% | -$2.76M-340% | $1.15M-64.2% | $3.2M— | ||
| $9.87M-7.3% | $10.64M-2.4% | $10.9M-11.5% | $12.33M+25.0% | $9.86M-9.7% | ||
| $31.74M-72.2% | $114.11M+1,077% | $9.7M+14.6% | $8.47M+13.3% | $7.47M-75.2% | ||
| -$107.22M-515% | -$17.45M+86.2% | -$126.81M-5.5% | -$120.15M-0.7% | -$119.29M-19.2% | ||
| -$101.61M-763% | -$11.78M+90.3% | -$121.25M-5.8% | -$114.61M-0.8% | -$113.76M-20.3% | ||
| -$101.61M-763% | -$11.78M+90.3% | -$121.25M-5.8% | -$114.61M-0.8% | -$113.76M-20.3% | ||
| -320.2%-310pp | -10.3%+1,240pp | -1,250.3%+104pp | -1,353.8%+169pp | -1,522.9%-1,208pp | ||
| -$107.22M-515% | -$17.45M+86.2% | -$126.81M-5.5% | -$120.15M-0.7% | -$119.29M-19.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Beam Therapeutics's income statement data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.